Operating Lease, Payments in USD of Iterum Therapeutics plc from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Iterum Therapeutics plc quarterly/annual Operating Lease, Payments history and change rate from Q1 2019 to Q3 2025.
  • Iterum Therapeutics plc Operating Lease, Payments for the quarter ending September 30, 2025 was $0.000, a 100% decline year-over-year.
  • Iterum Therapeutics plc Operating Lease, Payments for the twelve months ending September 30, 2025 was $152K, a 61.9% decline year-over-year.
  • Iterum Therapeutics plc annual Operating Lease, Payments for 2024 was $385K, a 8.76% increase from 2023.
  • Iterum Therapeutics plc annual Operating Lease, Payments for 2023 was $354K, a 50.1% decline from 2022.
  • Iterum Therapeutics plc annual Operating Lease, Payments for 2022 was $709K, a 24.9% decline from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

Iterum Therapeutics plc Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $152K $0 -$101K -100% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $253K $20K -$80K -80% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-05
Q1 2025 $333K $48K -$52K -52% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-13
Q4 2024 $385K $84K -$14K -14.3% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-07
Q3 2024 $399K $101K +$49K +94.2% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-14
Q2 2024 $350K $100K -$2K -1.96% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-05
Q1 2024 $352K $100K -$2K -1.96% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-13
Q4 2023 $354K $98K -$3K -2.97% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-07
Q3 2023 $357K $52K -$113K -68.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 $470K $102K -$167K -62.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 $637K $102K -$72K -41.4% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 $709K $101K -$154K -60.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $863K $165K +$9K +5.77% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $854K $269K +$1K +0.37% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $853K $174K -$91K -34.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $944K $255K -$178K -41.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-16
Q3 2021 $1.12M $156K +$59K +60.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $1.06M $268K +$15K +5.93% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $1.05M $265K -$68K -20.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 $1.12M $433K +$243K +128% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-28
Q3 2020 $873K $97K +$32K +49.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 $841K $253K +$10K +4.12% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-13
Q1 2020 $831K $333K +$143K +75.3% Jan 1, 2020 Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $688K $190K Oct 1, 2019 Dec 31, 2019 10-Q 2020-05-14
Q3 2019 $65K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $243K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $190K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-14

Iterum Therapeutics plc Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $385K +$31K +8.76% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-07
2023 $354K -$355K -50.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-07
2022 $709K -$235K -24.9% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $944K -$172K -15.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-16
2020 $1.12M +$290K +35.1% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
2019 $826K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.